Generated by GPT-5-mini| Sten Linnarsson | |
|---|---|
| Name | Sten Linnarsson |
| Birth date | 1952 |
| Birth place | Sweden |
| Fields | Developmental neuroscience, Neurobiology |
| Workplaces | Karolinska Institutet, University of Cambridge, Max Planck Institute |
| Alma mater | Uppsala University, Karolinska Institutet |
| Known for | Single-cell transcriptomics, Neural development, Neurodevelopmental disease models |
Sten Linnarsson
Sten Linnarsson is a Swedish neuroscientist known for contributions to developmental neurobiology and single-cell genomics. His work bridges molecular neuroscience, stem cell biology, and computational biology, influencing research at institutions such as Karolinska Institutet, University of Cambridge, and Max Planck Institute. Linnarsson's publications and collaborations intersect with researchers at Harvard University, Massachusetts Institute of Technology, and Broad Institute.
Linnarsson was born in Sweden and educated at Uppsala University and Karolinska Institutet, where he trained in molecular biology, neuroscience, and genetics alongside researchers associated with Nobel Prize committees and European Molecular Biology Laboratory. During his doctoral and postdoctoral periods he worked with mentors connected to University of Oxford, University of Cambridge, and Cold Spring Harbor Laboratory, engaging with techniques from Sanger sequencing era to next-generation sequencing platforms developed at Illumina and Pacific Biosciences.
Linnarsson held positions at Karolinska Institutet and maintained affiliations with the Max Planck Society and University of Cambridge, collaborating with groups at EMBL and Wellcome Sanger Institute. He established laboratories that incorporated technologies from Broad Institute, Harvard Medical School, and Massachusetts General Hospital, fostering collaborations with researchers from Stanford University, Yale University, and University College London. His group worked on projects funded by European Research Council, Wellcome Trust, and Knut and Alice Wallenberg Foundation, and he participated in consortia alongside researchers from NIH, European Molecular Biology Organization, and Howard Hughes Medical Institute.
Linnarsson pioneered applications of single-cell RNA sequencing and spatial transcriptomics to developmental neuroscience, interfacing methods from the Human Cell Atlas project, Allen Institute for Brain Science, and BRAIN Initiative. His studies integrated protocols from induced pluripotent stem cell platforms developed at Kyoto University and Salk Institute, and analytical frameworks inspired by algorithms from Google DeepMind, EMBL-EBI, and European Bioinformatics Institute. He contributed to mapping neuronal cell types in mammalian cortex with implications for diseases studied at Johns Hopkins University, University of California San Francisco, and Rockefeller University, and his work influenced approaches used at Dana–Farber Cancer Institute and Memorial Sloan Kettering Cancer Center. Collaborations with teams at Karolinska University Hospital, Uppsala University Hospital, and Lund University linked basic discoveries to translational research in neurodevelopmental disorders investigated at Massachusetts General Hospital and Children's Hospital of Philadelphia.
Linnarsson received recognition from Swedish and international organizations including prizes and grants associated with the European Research Council, Royal Swedish Academy of Sciences, and Swedish Society for Medical Research. His awards placed him among peers honored by the Nobel Assembly at Karolinska Institutet, EMBO, and the Royal Society, and he delivered invited lectures at institutions such as Cold Spring Harbor Laboratory, Gordon Research Conferences, and Keystone Symposia. He has been listed in program committees for meetings hosted by Society for Neuroscience, Human Cell Atlas, and International Society for Stem Cell Research.
Linnarsson's legacy encompasses mentorship of scientists who joined faculties at University of Oxford, University of Cambridge, Karolinska Institutet, and Uppsala University, and trainees who moved to industry groups at Genentech, AstraZeneca, and Pfizer. His interdisciplinary approach fostered ties with computational groups at ETH Zurich, Max Planck Institute for Brain Research, and Institut Pasteur. Through contributions to single-cell methods and neural cell atlases, his influence continues in projects at the Allen Institute, Human Cell Atlas, Wellcome Sanger Institute, and BRAIN Initiative, shaping research directions at centers such as Broad Institute, EMBL, and Cold Spring Harbor Laboratory.
Category:Swedish neuroscientists Category:Karolinska Institutet faculty Category:Uppsala University alumni